N-Desmethyl imatinib mesylate
CAS: 404844-03-7
Ref. 3D-ERA84403
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Información del producto
- Benzamide, N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-4-(1-piperazinylmethyl)-, monomethanesulfonate
- CGP 74588
- Benzamide, N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-4-(1-piperazinylmethyl)-, methanesulfonate (1:1)
N-Desmethyl imatinib mesylate is an active metabolite of Imatinib Mesylate, a drug used to treat metastatic colorectal cancer. The compound is an inhibitor of the tyrosine kinase activity of the epidermal growth factor receptor (EGFR) and is taken orally. N-Desmethyl imatinib mesylate has been shown to be effective in women with metastatic colorectal cancer, producing a hematologic response in 67% of patients. This compound has also been found to have a longer half-life than Imatinib Mesylate and may be used as a substitute for this drug in women with metastatic colorectal cancer who are unable to take oral medications.
Propiedades químicas
Consulta técnica sobre: 3D-ERA84403 N-Desmethyl imatinib mesylate
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
